Effect of Unani drugs with Mefenemic Acid in painful menstruatio
Not Applicable
Completed
- Conditions
- Health Condition 1: null- DysmenorrheaHealth Condition 2: N944- Primary dysmenorrhea
- Registration Number
- CTRI/2017/10/010168
- Lead Sponsor
- ational Institute of Unani Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 64
Inclusion Criteria
1. Patients aged from 14 to 35 years with a history of regular menstrual cycle (28±7 days) with spasmodic dysmenorrhea.
2. Having experienced menstrual pain of intensity from moderate to severe and the Visual Analog Scale > 4 cm for at least three menstrual cycles before this study.
Exclusion Criteria
1. Patients with secondary dysmenorrhea, and irregular menstrual cycles.
2. Patients using OCPs and contraceptive devices.
3. Patients with systemic diseases and malignancies.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary outcome was decrease of more than 50% of pain severity on Visual Analogue Scale (VAS) score for pain intensity. <br/ ><br>Pain relief was assessed by pain relief scaleTimepoint: third and fifth month
- Secondary Outcome Measures
Name Time Method Secondary outcome:â?¢Health related quality of life assessed by SF 12 and safety assessment <br/ ><br>Timepoint: Visit 3